{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T12:43:15Z","timestamp":1720528995099},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1016\/j.clinthera.2009.06.009","type":"journal-article","created":{"date-parts":[[2009,8,19]],"date-time":"2009-08-19T08:25:15Z","timestamp":1250670315000},"page":"1456-1468","source":"Crossref","is-referenced-by-count":16,"special_numbering":"P1","title":["Cost-effectiveness of quetiapine plus mood stabilizers compared with mood stabilizers alone in the maintenance therapy of bipolar I disorder: Results of a markov model analysis"],"prefix":"10.1016","volume":"31","author":[{"given":"Liberty","family":"Fajutrao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bj\u00f6rn","family":"Paulsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sherry","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Locklear","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2009.06.009_bib1","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0140-6736(02)07450-0","article-title":"Bipolar disorder","volume":"359","author":"M\u00fcller-Oerlinghausen","year":"2002","journal-title":"Lancet"},{"issue":"Suppl","key":"10.1016\/j.clinthera.2009.06.009_bib2","first-page":"S80","article-title":"Bipolar disorder: Disease burden","volume":"11","author":"Sajatovic","year":"2005","journal-title":"Am J Manag Care."},{"key":"10.1016\/j.clinthera.2009.06.009_bib3","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1185\/030079903125002801","article-title":"A systematic review evaluating health-related quality of life, work impairment, and healthcare costs and utilization in bipolar disorder","volume":"20","author":"Dean","year":"2004","journal-title":"Curr Med Res Opin."},{"key":"10.1016\/j.clinthera.2009.06.009_bib4","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1192\/bjp.bp.105.013870","article-title":"Sub-syndromal and syndromal symptoms in the longitudinal course of bipolar disorder","volume":"189","author":"Paykel","year":"2006","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.clinthera.2009.06.009_bib5","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2147\/NDT.S2703","article-title":"Differential diagnoses and management strategies in patients with schizophrenia and bipolar disorder","volume":"4","author":"Altamura","year":"2008","journal-title":"Neuropsychiatr Dis Treat."},{"issue":"Suppl 10","key":"10.1016\/j.clinthera.2009.06.009_bib6","first-page":"5","article-title":"Rationale for long-term treatment of bipolar disorder and evidence for long-term lithium treatment","volume":"63","author":"Goodwin","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.clinthera.2009.06.009_bib7_1","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1177\/0269881103017002003","article-title":"Evidence-based guidelines for treating bipolar disorder: Recommendations from the British Association for Psychopharmacology","volume":"17","author":"Goodwin","year":"2003","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.clinthera.2009.06.009_bib7_2","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1177\/0269881103017002003","article-title":"Evidence-based guidelines for treating bipolar disorder: Recommendations from the British Association for Psychopharmacology","volume":"17","author":"Goodwin","year":"2003","journal-title":"J Psychopharmacol"},{"issue":"Suppl","key":"10.1016\/j.clinthera.2009.06.009_bib8","first-page":"S178","article-title":"Treatment of bipolar disorder: The evolving role of atypical antipsychotics [published correction appears in Am J Manag Care. 2008;14:76]","volume":"13","author":"Perlis","year":"2007","journal-title":"Am J Manag Care."},{"key":"10.1016\/j.clinthera.2009.06.009_bib9","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.euroneuro.2005.02.006","article-title":"Quetiapine or haloperidol as monotherapy for bipolar mania\u2014a 12-week, double-blind, randomised, parallel-group, placebo-controlled trial","volume":"15","author":"McIntyre","year":"2005","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.clinthera.2009.06.009_bib10","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4088\/JCP.v66n0116","article-title":"A randomized, double-blind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder","volume":"66","author":"Bowden","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.clinthera.2009.06.009_bib11","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1176\/appi.ajp.162.7.1351","article-title":"A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression","volume":"162","author":"Calabrese","year":"2005","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.clinthera.2009.06.009_bib12","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1097\/01.jcp.0000248603.76231.b7","article-title":"Efficacy of quetiapine monotherapy in bipolar I and II depression: A double-blind, placebo-controlled study (the BOLDER II study) [published correction appears in J Clin Psychopharmacol. 2007;27:51]","volume":"26","author":"Thase","year":"2006","journal-title":"J Clin Psychopharmacol."},{"key":"10.1016\/j.clinthera.2009.06.009_bib13","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jad.2008.06.001","article-title":"Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126)","volume":"109","author":"Vieta","year":"2008","journal-title":"J Affect Disord."},{"key":"10.1016\/j.clinthera.2009.06.009_bib14","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1176\/appi.ajp.2008.08020189","article-title":"Maintenance treatment for patients with bipolar I disorder: Results from a North American study of quetiapine in combination with lithium or divalproex (Trial 127)","volume":"166","author":"Suppes","year":"2009","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.clinthera.2009.06.009_bib15","series-title":"Bipolar Disorder. The Management of Bipolar Disorder in Adults, Children and Adolescents, in Primary and Secondary Care","year":"2006"},{"key":"10.1016\/j.clinthera.2009.06.009_bib16_1","doi-asserted-by":"crossref","first-page":"iii","DOI":"10.3310\/hta11390","article-title":"A systematic review and economic model of the clinical effectiveness and cost-effectiveness of interventions for preventing relapse in people with bipolar disorder","volume":"11","author":"Soares-Weiser","year":"2007","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.clinthera.2009.06.009_bib16_2","doi-asserted-by":"crossref","first-page":"ix","DOI":"10.3310\/hta11390","article-title":"A systematic review and economic model of the clinical effectiveness and cost-effectiveness of interventions for preventing relapse in people with bipolar disorder","volume":"11","author":"Soares-Weiser","year":"2007","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.clinthera.2009.06.009_bib17","series-title":"Poster presented at: 3rd Biennial Conference of the International Society for Bipolar Disorders","article-title":"Quetiapine in the maintenance treatment of bipolar I disorder: Combined data from two long-term, phase III studies","author":"Brecher","year":"2008"},{"key":"10.1016\/j.clinthera.2009.06.009_bib18","series-title":"Hospital Episode Statistics. England: Financial Year 2003\u20132004","year":"2004"},{"key":"10.1016\/j.clinthera.2009.06.009_bib19","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1177\/0269881106068395","article-title":"Cost effectiveness of olanzapine in prevention of affective episodes in bipolar disorder in the United Kingdom","volume":"21","author":"McKendrick","year":"2007","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.clinthera.2009.06.009_bib20","series-title":"Decision Modelling for Health Economic Evaluation","author":"Briggs","year":"2006"},{"key":"10.1016\/j.clinthera.2009.06.009_bib21","series-title":"British National Formulary","year":"2006"},{"key":"10.1016\/j.clinthera.2009.06.009_bib23","series-title":"Guide to the Methods of Technology Appraisal","year":"2006"},{"key":"10.1016\/j.clinthera.2009.06.009_bib24","doi-asserted-by":"crossref","first-page":"322","DOI":"10.18553\/jmcp.2006.12.4.322","article-title":"The cost-effectiveness of lamotrigine in the maintenance treatment of adults with bipolar I disorder","volume":"12","author":"Calvert","year":"2006","journal-title":"J Manag Care Pharm."},{"key":"10.1016\/j.clinthera.2009.06.009_bib25","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0167-6296(01)00130-8","article-title":"The estimation of a preference-based measure of health from the SF-36","volume":"21","author":"Brazier","year":"2002","journal-title":"J Health Econ."},{"key":"10.1016\/j.clinthera.2009.06.009_bib26","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1001\/archpsyc.60.4.392","article-title":"A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder [published correction appears in Arch Gen Psychiatry. 2004;61:680]","volume":"60","author":"Bowden","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.clinthera.2009.06.009_bib27","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.4088\/JCP.v64n0906","article-title":"A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder","volume":"64","author":"Calabrese","year":"2003","journal-title":"J Clin Psychiatry"},{"issue":"Suppl 1","key":"10.1016\/j.clinthera.2009.06.009_bib28","first-page":"26","article-title":"Olanzapine's efficacy for relapse prevention in bipolar disorder: A randomised double-blind placebo-controlled 12-month clinical trial","volume":"6","author":"Tohen","year":"2004","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.clinthera.2009.06.009_bib29","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1176\/appi.ajp.163.2.247","article-title":"Randomized, placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapine","volume":"163","author":"Tohen","year":"2006","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.clinthera.2009.06.009_bib30","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/hec.864","article-title":"Does NICE have a cost-effectiveness threshold and what other factors influence its decisions? A binary choice analysis","volume":"13","author":"Devlin","year":"2004","journal-title":"Health Econ."},{"key":"10.1016\/j.clinthera.2009.06.009_bib31","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1192\/bjp.180.3.227","article-title":"Annual cost of bipolar disorder to UK society","volume":"180","author":"Das Gupta","year":"2002","journal-title":"Br J Psychiatry"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291809001921?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291809001921?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,9]],"date-time":"2021-10-09T20:23:48Z","timestamp":1633811028000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291809001921"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":32,"alternative-id":["S0149291809001921"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2009.06.009","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}